Home

Ipca Laboratories Limited

IPCALAB.NSNSEHealthcare
₹1,749.50Today3.78% · +₹63.70
Day rangeTrading above day high
₹0.00₹0.00
Open
₹0.00
Prev close
₹1,685.80
AskWarren SignalsUpdated 22:27 IST
Momentum Bullish(+3.78% today)Volume 1% Below Avg52W Position Mid-range
Volume
2.3L
1% below avg
Avg vol (20D)
2.3L
20-day baseline
Mkt cap
₹44,357.65Cr
Mid Cap
P/E TTM
38.8×

Trade Ipca Laboratories Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetes, diabetology, emollients/protectives, fever, gastroenterology, haematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, regenerative, respiratory, rheumatology, and urology. The company also exports its products to Europe, Africa, the Americas, rest of Asia, the Commonwealth of Independent States, and Australasia. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.

Classification

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Stock ExchangeNSE

Identifiers

Ticker SymbolIPCALAB.NS

Company Info

HeadquartersNot available
Employees17,210
Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.